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Abstract A cDNA encoding a second type of a progestogen
receptor (ePR2) was isolated from the same library as we had
previously cloned a functional PR (ePR1) in eel testis. The amino
acid sequence of the ePR2 shows low homology with ePR1
(34%), but both PRs showed progestogen-dependent transac-
tivation in transfection experiment. Tissue distribution of
ePR2 mRNA was clearly different from that of ePR1. Pro-
tein interaction between two PRs was demonstrated in vitro by
a glutathione S-transferase pull-down assay. These results
indicate that ePR2 is also a functional PR. This is the first
isolation of two different functional PR molecules from a
vertebrate. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Progestogen receptor (PR) is a ligand-dependent transcrip-
tional factor which belongs to a large family of nuclear re-
ceptors [1]. It has been shown that members of the nuclear
receptor superfamily, such as retinoic acid receptor, retinoid X
receptor and thyroid hormone receptor, have multiple sub-
types and isoforms [1]. In the case of the steroid receptor
subfamily, two or three subtypes have been reported for estro-
gen receptor (ER, ERK, ERL and ERQ) in some mammals and
teleost ¢shes [2,3,31] and androgen receptor (AR, ARK and
ARL) in the Japanese eel, Anguilla japonica [4]. Although no
PR subtypes have been reported, the PR has two isoforms
(form A and form B). Chicken and human PR homologues
originate from translational initiation at two in-phase ATG
codons [5^7].
17K,20L-Dihydroxy-4-pregnen-3-one (17K,20L-DP) plays an
important role in inducing oocyte maturation and spermiation
in several teleost ¢shes including the Japanese eel [8].
Although the mechanisms of the synthesis and action of this
steroid have extensively been studied in the ovaries of several
teleost ¢shes, the progestogen signaling system in gonads is
not understood. In order to understand this problem, we have
recently isolated and characterized a cDNA encoding a nu-
clear PR (ePR1) from a Japanese eel testis cDNA library. In
transfection experiments using COS7 cells, the ePR1 showed
progestogen-dependent activation of transcription. Thus, it
was concluded that the ePR1 is a functional eel PR [9].
Here, we describe the isolation and characterization of an-
other cDNA encoding a second type of ePR (ePR2) from the
testis of the Japanese eel. Binding properties and the trans-
activation function of ePR2 were determined by expressing
the cDNA in transiently transfected human embryonic kidney
(HEK) 293 cells. The ePR mRNA levels in various tissues
from eels were measured by reverse transcription-polymerase
chain reaction (RT-PCR). The molecular interaction of both
ePR proteins was also demonstrated by a glutathione S-trans-
ferase (GST) pull-down assay.
2. Materials and methods
2.1. Animals
Cultivated male Japanese eels (150^200 g body weight) were pur-
chased from a commercial eel supplier (Marute Shouten, Hekinan
City, Aichi Prefecture, Japan). They were kept in recirculating fresh-
water tanks with a capacity of 500 l at 20‡C. Fish were not fed
throughout the experimental period.
2.2. Isolation of cDNA clones
A fragment of ePR2 subtype, whose sequence was partially di¡erent
from ePR1, was isolated after a testis cDNA library from Japanese
eels killed 1 and 3 days after human chorionic gonadotropin injection
was screened using a PCR-ampli¢ed product as a probe [10]. Since the
5P-terminus of the clone was truncated, 5P-rapid ampli¢cation of
cDNA ends (5P-RACE) was performed using a Marathon cDNA
Ampli¢cation kit (Clontech). The insert cDNA was nest-deleted at
both ends using ExoIII/Mung bean nuclease. Sequencing was per-
formed using the ABI PRISM Dye Terminator cycle sequencing kit
(Applied Biosystems).
2.3. Construction of plasmid vectors
pcDNA-ePR2 was constructed by PCR ampli¢cation of the entire
protein coding region (amino acids 1^689) of the ePR2, using primers
which introduced an EcoRV site and in-frame Kozak sequence [11] at
the 5P-end and a XhoI site at the 3P-end. The EcoRV^XhoI fragment
was inserted at the corresponding site of pcDNA3.1(+) (Invitrogen).
pcDNA-ePRrev, which had the pcDNA-ePR2 inserted in the reverse
direction, was also prepared as a negative control. An ePR1 expres-
sion vector, named pcDNA-ePR1, was constructed after digestion an
insert containing the entire protein coding sequence of the ePR1 from
pSG5eDPR [9] with EcoRI, into the same site of pcDNA3.1(+). A
0014-5793 / 02 / $22.00 ß 2002 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 0 1 ) 0 3 2 2 0 - 3
*Corresponding author. Fax: (81)-564-55 7556.
E-mail address: nagahama@nibb.ac.jp (Y. Nagahama).
1 The nucleotide sequence data reported in this paper will appear in
the DDBJ/EMBL/GenBank nucleotide sequence databases with
accession number AB028024.
2 Present address: Sado Marine Biological Station, Faculty of
Science, Niigata University, Tassha 87, Aikawa, Sado Island,
Niigata 952-2135, Japan.
FEBS 25605 17-12-01
FEBS 25605 FEBS Letters 510 (2002) 77^82
progestogen-regulated reporter vector, named MMTV-luc, was con-
structed as described previously [9]. Another progestogen-regulated
reporter vector containing two copies of consensus steroid-responsive
element, named SREX2-luc, was also constructed by ligating the
SREX2 oligonucleotide (see below for sequence) into MluI^BglII-di-
gested pGVP2 promoter vector which contains the Photinus pyralis
luciferase gene (Toyo Ink). The SREX2 oligonucleotide was made
after annealing 5P-CGCGTAGAACACAGTGTTCTGATCCCGG-
GACTAGAACACAGTGTTCTA-3P and 5P-GATCTAGAACACT-
GTGTTCTAGTCCCGGGATCAGAACACTGTGTTCTA-3P.
The GST expression vector, named pGST, was constructed by in-
sertion of PCR ampli¢cation of the entire protein coding region (ami-
no acids 1^240) of GST using pGEX-4T-2 (Pharmacia) as template,
speci¢c forward primer, which introduced an EcoRV site and in-frame
Kozak sequence at the 5P-end, and reverse primer with a multiple
cloning site of pGEX-4T-2, into pcDNA3.1(+) (Invitrogen) at the
EcoRV^NotI site after digestion with EcoRV and NotI. The pGST-
ePR1 and pGST-ePR2 were generated by in-frame ligation of the
NotI fragment from PCR products of pcDNA-ePR1 and pcDNA-
ePR2, respectively, using a primer which introduced a NotI site at
the 5P-end and BGH reverse primer (Invitrogen) into the correspond-
ing sites of pGST.
2.4. Hormone-binding analysis
Hormone-binding analyses were carried out as described previously
except for the use of HEK 293 cells and pcDNA3.1(+) vector [12]. In
order to normalize for variation in transfection e⁄ciency, pRL-TK,
which contains the Renilla reniformis luciferase gene with the herpes
simplex virus thymidine kinase promoter, was co-transfected with
each expression vector for ePR.
2.5. Transactivation assays
Transient transfection experiments were carried out as described
previously [4].
2.6. RT-PCR for PR mRNA
RT-PCR was carried out as described previously [4]. The sequences
of the primers are as follows: 5P-TCATTGGCAGATAACGAAG-
GACTGGC-3P, for sense of ePR2; 5P-GCGACTTCAAGGAATT-
GTGTGTCTCA-3P, for antisense of ePR2; 5P-CATACTCGGAG-
TCTTTTGGGAGTTATGTG-3P, for sense of ePR1; 5P-TCGC-
AGTATTGGTCAGATAAGATG-3P, for antisense of ePR1.
Both sense and antisense primers for eel L-actin were the same as
described previously [13].
2.7. GST pull-down assay
In the TNT-coupled RRL system (Promega) with T7 RNA poly-
merase, pcDNA-ePR1 or pcDNA-ePR2 was translated in the presence
of [35S]methionine, and pGST-ePR1, pGST-ePR2 or pGST was trans-
lated in the absence of radiolabeled amino acids. 1 Wl of each ePR-
containing lysate was mixed with 5 Wl lysate containing GST-ePR1,
GST-ePR2 or GST protein. Samples had been incubated for 15 min
on ice before 50 Wl glutathione-Sepharose (Pharmacia) diluted in
phosphate-bu¡ered saline (PBS) was added to each sample followed
by 30 min of incubation on ice. The Sepharose beads were washed
four times in PBS/0.1% Triton X-100, and bound proteins were eluted
by incubation in SDS bu¡er for 2 min at 100‡C. Hormone (17K,20L-
DP; 10 nM) was included in all bu¡ers, where applicable. Lysate of
each ePR was loaded as input together with the eluted samples on a
12.5% SDS^PAGE. The gel was dried, exposed to an imaging plate
and examined using an image analyzer BAS-2000 II (Fujix, Japan).
Fig. 1. Comparison of ePR2 protein with ePR1 (A), other steroid hormone receptors in eel (B) and PRs of several species (C). The functional
A/B to E/F domains are schematically represented, with the numbers of amino acid residues indicated (A). Percentage homology of the domain
relative to the Japanese eel PR2 is depicted. Clustal analysis of the full-length receptor sequences (B) and the E (ligand-binding) domains (C)
using the MegAlign/DNASTAR software was used to develop alignments and phylogenetic trees. AR, androgen receptor; GR, glucocorticoid
receptor; ER, estrogen receptor; e, eel ; h, human; rb, rabbit; m, mouse; r, rat; c, chicken.
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2.8. Statistics
Data were analyzed by one-way factorial analysis of variance and
Sche¡e’s F-test as the multiple comparison test to determine signi¢-
cant di¡erence between individuals; P90.01 was considered signi¢-
cant.
3. Results
3.1. Sequence homology with other steroid hormone receptors
During cloning of eel ARK cDNA, one positive clone,
whose sequence was partially di¡erent from ePR1, was ob-
tained. This insert is 1538 bp in size, and the 5P-terminus of
the cDNA was truncated. Thus, 5P-RACE was preformed by
using primer (corresponding to 180^209 bp of the clone) de-
signed so that the PCR product overlapped with the 5P-termi-
nus truncated clone at an ePR2-unique sequence. Based on
the 5P-terminus truncated clone and the 5P-RACE product
obtained, the nucleotide sequence and the deduced amino
acid sequence of ePR2 were determined. The sequence con-
tains a long open reading frame encoding 689 amino acid
residues (molecular mass 76 312 Da). Comparison of the ami-
no acid sequence of ePR2 with those of eel steroid hormone
receptors and PRs of other species is shown in Fig. 1. The eel
gene sequence could be subdivided into four to ¢ve domains
(A^F) as de¢ned by Krust et al. [14]. The putative DNA-
binding domain (DBD; residues 317^402) and ligand-binding
domain (LBD; residues 438^689) show high homology with
those of other PRs including ePR1 (DBD: 84^89%, LBD: 65^
81%). The other domains show low homology (6 33%).
3.2. Binding properties of ePRs expressed in HEK 293 cells
Whole cell extracts from pcDNA-ePRs transfected groups
contained a protein which speci¢cally bound 17K,20L-DP
(Fig. 2A). Scatchard analysis using [3H]17K,20L-DP as a li-
gand revealed that ePR1 had a single class of high a⁄nity
binding sites for 17K,20L-DP, with a dissociation constant
(Kd) of 2.44 nM and a Bmax of 1.25 pmol/relative luciferase
unit (RLU) (Fig. 2B). Similar binding properties were ob-
served for ePR2 with a Kd of 2.38 nM and a Bmax of 1.13
pmol/RLU (Fig. 2C).
3.3. Progestogen-dependent transactivation function of ePR2
expressed in HEK 293 cells
The induction of progestogen-regulated reporter activity
with 17K,20L-DP was shown in Fig. 3. ePR2 induced a
three-fold response on both MMTV-luc and SREX2-luc
when 100 nM 17K,20L-DP was added to the medium. ePR1
produced a larger fold induction of both reporters when ex-
amined under the same conditions. When pcDNA-ePRrev
was transfected, no induction was found even with the hor-
mone.
Ligand speci¢city for the induction of progestogen-regu-
lated reporter activity was examined by incubation with 100
nM of various steroids (Fig. 3C). Four major progestogens in
teleosts such as progesterone (P4), 17K,20L-DP, 20L-hydroxy-
4-pregnen-3-one (20L-P) and 21-hydroxy-P4 (11-deoxycorti-
costerone; 11-DOC) [15] were e¡ective in inducing luciferase
activity. P4 and 17K,20L-DP were most potent. 20L-P and 11-
DOC were also e¡ective, but their potencies were signi¢cantly
lower than that of 17K,20L-DP (P6 0.01). Interestingly,
17K,21-dihydroxy-P4 (S) and 17K,20L,21-trihydroxy-4-preg-
nen-3-one (20L-S) were ine¡ective in inducing luciferase activ-
ity in ePR2, although ePR1 was signi¢cantly stimulated by
these steroids. Other progesterone-related steroids (17K-hy-
droxy-P4 (17K-P), 11L-hydroxy-P4, pregnenolone, and
17K,20K-dihydroxy-4-pregnen-3-one (17K,20K-DP)), and oth-
Fig. 2. Binding kinetics of 17K,20L-DP to ePRs. A: Saturation anal-
ysis of [3H]17K,20L-DP binding to ePRs expressed in HEK 293
cells. B, C: Scatchard plot of ePR1 (B) and ePR2 (C). The esti-
mated dissociation constants (Kd) for ePR1 and ePR2 are 2.44 nM
and 2.38 nM, respectively.
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er classes of steroids (cortisol, aldosterone, testosterone, 11-
ketotestosterone, and estradiol-17L) were ine¡ective.
Both 17K,20L-DP and P4 stimulated luciferase activity
through ePR2 in a dose-dependent manner (Fig. 3D). The
median e¡ective doses of 17K,20L-DP and P4 were
1.2U10310 nM and 2.6U1039 nM, respectively. When doses
less than 10 nM of steroids were used, the fold induction of
reporter activity with 17K,20L-DP was signi¢cantly higher
than that with P4 (P6 0.01).
3.4. Tissue distribution of PR mRNA
To determine the relative distribution of ePR1 and ePR2
mRNA, poly(A) RNA was isolated from various tissues
from male and female eels and used for RT-PCR using prim-
ers speci¢c for each ePR subtype. The relative distribution of
both ePR subtypes was quite di¡erent, although this assay
Fig. 3. Transcriptional activities of ePR2. A, B: 17K,20L-DP-dependent transcriptional activities of ePRs tested with the MMTV-luc (A) and
SREX2-luc (B) reporter plasmids. HEK 293 cells were transiently transfected with an ePR expression vector together with the reporter vector.
Cells were incubated with or without 100 nM of 17K,20L-DP for 48 h. Data are expressed as a ratio of each group: mock without 17K,20L-
DP. *P6 0.001. C: Transcriptional activities for various steroids. Cells, transiently transfected with the MMTV-luc vector together with an
ePR1 or ePR2 expression vector, were incubated with or without 100 nM of various steroids for 48 h. Data are expressed as a ratio of steroid:
vehicle (ethanol). a;b;x;y;z;wGroups sharing the same letter codes were not signi¢cantly di¡erent at P6 0.01, and groups from a to b and from w
to z were signi¢cantly di¡erent from vehicle group of ePR2 and ePR1, respectively, at P6 0.01. D: Dose^response pro¢le of ePR2 activation
by progestogens. Cells, transiently transfected with the MMTV-luc vector together with an ePR2 expression vector, were incubated with in-
creasing concentrations of 17K,20L-DP or progesterone (0.01^100 nM) or with no ligand for 48 h. Asterisks show that the fold induction with
17K,20L-DP was signi¢cantly di¡erent from that of P4 at the same dose at P6 0.01. Each column represents the mean of triplicate determina-
tions, and vertical bars represent the standard deviation. Lack of error bars on some columns is due to the errors being too small to show
graphically.
Fig. 4. Distribution of PRs mRNA in tissues of Japanese eel. Poly-
(A) RNA was prepared from gill, heart, head kidney, spleen, liver,
muscle, testis and brain of male eels and ovary of female eels. L-Ac-
tin was used as a positive control. mRNAs of both PR subtypes
were detected by RT-PCR.
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was only semiquantitative (Fig. 4). ePR2 mRNA was detected
in gill, spleen, testis, brain and ovary, whereas ePR1 mRNA
was observed in kidney, spleen, liver and testis.
3.5. GST pull-down assay
Both in vitro translated products of ePR1 and ePR2 were
pulled down by GST-fused ePR1 or ePR2 proteins (Fig. 5).
GST protein alone pulled neither ePR1 nor ePR2 down.
4. Discussion
The present study demonstrates the existence of a novel PR
in the Japanese eel. The ePR2 has the putative DBD and LBD
showing high homology with ePR1. The other domains show
low homology. The size of ePR2 is shorter than ePR1 due to
the shorter length of N-terminal A^B domain of ePR2. Judg-
ing from these structures, ePR1 and ePR2 are not isoforms
derived from translational initiation at two in-phase ATG
codons, alternative splicing, or tetraploidy. Phylogenetical
analysis showed that ePR1 and ePR2 are distinct gene prod-
ucts and evolutionarily related but not recently duplicated.
We have previously cloned and characterized two subtypes
of ARs (ARK and ARL) from the eel testis cDNA library
[9]. It is widely accepted that an ancestral steroid hormone
receptor split four genes (AR, PR, glucocorticoid receptor
(GR) and mineral corticoid receptor (MR)) by two waves of
gene duplications in vertebrates [16,17]. However, it is likely
that AR and PR diverged before the last gene duplication,
because both AR and PR have two subtypes. It is important
to determine whether two subtypes of GR and MR are also
present in the Japanese eel.
In an earlier study, we showed that a bacterial recombinant
ePR1-LBD (parts of the ePR1 molecule corresponding to the
LBD of DPR, residues 459^710) bound 17K,20L-DP with a
Kd of 24 nM [9]. In the present study, we synthesized the
entire protein of ePR1 and ePR2 using HEK 293 cells. These
two proteins showed similar biochemical properties and spe-
ci¢cally bound 17K,20L-DP. However, their a⁄nity for
17K,20L-DP was higher (approximately 10-fold) than that of
the recombinant ePR1 protein.
A transactivation assay using a progestogen-regulated re-
porter vector containing the luciferase gene with the MMTV
promoter into COS7 cells revealed that several progestogens
including 17K,20L-DP were e¡ective in inducing luciferase ac-
tivity in ePR1, showing that ePR1 is a functional eel PR [9].
The present study also demonstrated the 17K,20L-DP-depen-
dent transactivation function of ePR2 in HEK 293 cells. In
the presence of 17K,20L-DP, both ePR1 and ePR2 activated
the transcription of the luciferase gene under the control of
MMTV or SREX2-SV40 promoter with a slightly lower lucif-
erase activity in 293 cells transfected with ePR2. These results
show that the cloned ePR2 cDNA also encodes a functional
eel PR.
We have previously shown that the major native ligand of
ePR1 is 17K,20L-DP [9]. This conclusion was based on:
(1) 17K,20L-DP was the most e¡ective steroid in inducing lu-
ciferase activity, (2) P4 is considered to be an intermediate in
the synthesis of potent steroids in teleosts, and 17K,20L-DP
and/or 20L-S are the major progestogens in teleosts, (3)
17K,20L-DP has been identi¢ed as the major oocyte matura-
tion-inducing hormone (MIH) of Japanese eel, and (4) eel
gonads produce a large amount of 17K,20L-DP in vitro, but
not 20L-P, 11-DOC, P4 or 20L-S, when the precursor is added
to incubation medium [9]. The present study also showed that
17K,20L-DP was the most e¡ective steroid in inducing lucif-
erase activity in ePR2. P4 was also highly e¡ective, but its
median e¡ective dose (2.6U1039 nM) was much higher than
that of 17K,20L-DP (1.2U10310 nM). It is concluded from
these results that like ePR1, the major native ligand of
ePR2 is 17K,20L-DP.
Ligand speci¢city for the induction of progestogen-regu-
lated reporter activity of ePR2 was very similar to that of
ePR1. Steroids with high transcriptional activity in ePR1
and ePR2 have previously been shown to be highly e¡ective
in inducing ¢nal maturation of ¢sh oocytes in vitro [14] with
the exception that 20L-S, which has been identi¢ed as the
MIH of spotted seatrout [18], was ine¡ective in inducing lu-
ciferase activity in ePR2, although some activity was found in
ePR1. Pinter and Thomas [19] demonstrated the presence of
the nuclear PR in the ovary of spotted seatrout. In their
studies, 20L-S and 17K,20L-DP demonstrated very high a⁄n-
ity for this receptor. However, in the Japanese eel, the levels
of 20L-S are very low in the eel ovary [20]. In the present
study, the 20K epimer of 17K,20L-DP, 17K,20K-DP, did not
induce transcriptional activity through ePRs. This steroid is
found in testicular incubations or plasma of several teleosts
[15], but has been shown to be less potent in inducing oocyte
maturation. The precursors for 17K,20L-DP (17K-P and preg-
nenolone) were also ine¡ective in inducing transcriptional
activity of ePRs. Taken together, it is possible that ePRs
play a role in the signaling system associated with progesto-
gen-induced oocyte maturation in teleosts.
A⁄nity to C21 steroid of both ePRs was di¡erent from
that of mammalian PR [21]. In mammal 11-DOC binds
weakly to PR, but the relative binding a⁄nity (RBA) of
MR to that steroid (RBA = 75V100) is higher than that of
PR (RBA = 25V50). S binds to MR, but not to PR in mam-
mals. In the present study, 11-DOC induced transcriptional
activity in both ePRs and S was e¡ective in ePR1. These
steroids have been shown to be produced in gonads of several
teleosts and to induce ¢nal oocyte maturation (see [15]).
There are two minor di¡erences in transactivity for ligands
between ePR2 and ePR1. First, 20L-S and S did not show any
signi¢cant transcriptional activity in ePR2, whereas they in-
duced weak activity in ePR1. Second, when a concentration of
100 nM was used, P4 and 17K,20L-DP were equally e¡ective
in ePR2, whereas 17K,20L-DP was more e¡ective than P4 in
ePR1. The Scatchard analysis based on the present binding
assay revealed that both proteins showed similar Bmax. Since
the variation in transfection e⁄ciency was normalized in each
experiment by using the same internal control vector, it is
assumed that similar levels of both receptors were expressed
after transient transfection in the reporter assay. We also re-
ported previously that the transactivity for androstenedione
and synthetic androgens di¡ered in eel ARK and ARL [4].
The physiological responses to estrogen are known to be
mediated within speci¢c tissues by at least two estrogen re-
ceptors, ERK and ERL [22]. Studies of the receptors’ tissue
distribution and expression pattern in mammals indicate that
ERK has a broad expression pattern, whereas ERL has a more
focused pattern with high levels in the ovary, prostate, epidi-
dymis, lung, and hypothalamus [23,24]. Similarly, tissue dis-
tribution of ARK and ARL mRNA expression is quite di¡er-
ent in eel. eARK mRNA has a broad expression pattern,
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whereas eARL mRNA was observed only in spleen, muscle,
and testis [9]. In the present study, ePR2 mRNA was detected
in gill, spleen, testis, brain, and ovary, whereas ePR1 mRNA
was observed in kidney, spleen, liver, and testis. Di¡erences in
tissue distribution of ePR mRNA are predictable because
their A/B domains, which contain a region of transactivation
function strongly dependent on cell and promoter types but
less on ligand-binding, show low homology. In mammals, PRs
were detected in uterus, ovary, vagina, testis, breast, brain,
vascular endothelium, thymus, pancreatic islet, osteoblast-
like cell, and lung [25]. In non-mammalian species, PRs
were also detected in oviduct of chicken [5] and turtle [26],
liver of turtle [27], testis of shark [28] and ovary of seatrout
[20].
In mammals and chicken, several target genes of P4-PR
have been reported (uteroglobin in rabbit uterus, osteonectin
in mouse bone, and ovalbumin in chicken oviduct) [25]. No
such studies have been performed in teleosts. It is necessary to
identify target genes of piscine PRs to uncover their physio-
logical roles. In this connection, it is of interest to note that
although both ePR1 and ePR2 were expressed in spleen and
testis in the Japanese eel, the relative expression of both PRs
was di¡erent between two tissues. Recently, it has been re-
ported that ERK and ERL can heterodimerize with each oth-
er, suggesting their cross-talking possibilities [29,30]. Similarly,
our results using a GST pull-down assay also show that ePR1
and ePR2 form heterodimers. It is thus possible that ePR1
and ePR2 may cooperate in regulating progestogen-responsive
gene expression in cell types in which they are co-expressed. In
this study, ePR1 and ePR2 mRNAs were co-expressed in
spleen and testis. Further in situ hybridization studies will
be necessary to determine whether both subtypes co-exist in
the same cell.
In conclusion, a novel PR subtype, ePR2, was cloned and
characterized. We suggest that this novel type of PR is named
eel PRL to di¡erentiate it from ePR1 (PRK) cloned previously
[9]. Further studies are necessary to discern the full roles of
each ePR in the progestogen signaling system.
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Fig. 5. GST pull-down assay. Both ePR1 and ePR2 proteins were
labeled with [35S]methionine by translation in vitro using the TNT-
coupled reticulocyte lysate system (Promega), shown in the ¢rst two
lanes at the amount of 10% input. After incubation with GST,
GST-ePR1 or GST-ePR2 proteins, samples were subsequently incu-
bated with glutathione-Sepharose (Pharmacia), washed, eluted in
SDS bu¡er, and separated on 12.5% SDS^PAGE.
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